[Contract Development] Realizing new formulation development with "one-step" nucleated tablet manufacturing.
Support for solving formulation challenges using our unique OSDrC technology! In addition to the advantages of conventional core tablets, various functions can be added to the formulation!
Do you have any concerns or requests regarding formulation? - Unable to create tablets - Want to improve stability against light - Want to create tablets that do not expose the API even when split - Want to control the timing of API dissolution - Want to reduce the contact area between APIs in combination products These concerns and requests may be resolved using OSDrC technology! If you are interested, please check the details of OSDrC technology at the link below (Sanwa Chemical Research Institute's special site on Ipros) or download the main brochure and case study materials (technical documentation) for your review. If you have any questions, please feel free to contact us. ◎●◎ Sample Presentation ◎●◎ For those who wish, we will send you tablet samples made using OSDrC technology. *: OSDrC technology refers to our unique formulation technology that allows for the production of core tablets in one step with a rotary tablet press. By supplying the inner core in powder form, we can avoid tablet pressing issues such as core misalignment that occur during conventional core tablet manufacturing, and we can also expect benefits in terms of quality assurance.
Inquire About This Product
catalog（2）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.
